Further assessment of serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) can differentiate between primary and secondary hypogonadism.11 This difference in the classification of primary and secondary hypogonadism is important in determining which therapies will work to help increase testosterone levels. This evidence concerns the gene BRD2 and hypogonadotropic hypogonadism.